Tasso Partners, LLC - 15 Nov 2025 SCHEDULE 13G Report for Orchestra BioMed Holdings, Inc. Common Stock, par value $0.0001 per share (OBIO)

Filing Manager
Tasso Partners, LLC
Reporting Manager
Dana Lorenzo
Security
Orchestra BioMed Holdings, Inc. Common Stock, par value $0.0001 per share
Symbol
OBIO
Shares outstanding
56,338,036 shares
Disclosed Ownership
3,098,592 shares
Ownership
5.5%
Form type
SCHEDULE 13G
Filing time
19 Nov 2025, 16:05:36 UTC
Date of event
15 Nov 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"Tasso Partners, LLC disclosed 5.5% ownership in Orchestra BioMed Holdings, Inc. Common Stock, par value $0.0001 per share (OBIO) on 15 Nov 2025."

Quick Takeaways

  • Tasso Partners, LLC filed SCHEDULE 13G for Orchestra BioMed Holdings, Inc. Common Stock, par value $0.0001 per share (OBIO).
  • Disclosed ownership: 5.5%.
  • Date of event: 15 Nov 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 19 Nov 2025, 16:05.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Tasso Partners, LLC 5% 2,849,592 0 2,849,592 /s/ Dana Lorenzo/Manager of Tasso Capital, LLC, which controls Tasso Partners, LLC Dana Lorenzo/Manager of Tasso Capital, LLC, which controls Tasso Partners, LLC
Dana Lorenzo 5.5% 3,098,592 249,000 2,849,592 /s/ Dana Lorenzo Dana Lorenzo

Sponsored